Economic evaluation of healthcare technologies using primary research

Evidence-Based Nursing

Volumn 11, Issue 3, 2008, Pages 67-71

  Soares, Marta ^a   Dumville, Jo C ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH SERVICES RESEARCH; MEDICAL TECHNOLOGY; STANDARD;

EVIDENCE-BASED MEDICINE; HEALTH SERVICES RESEARCH; TECHNOLOGY, MEDICAL;

EID: 46349102442     PISSN: 13676539     EISSN: 14689618     Source Type: Journal    
DOI: 10.1136/ebn.11.3.67     Document Type: Note

References (20)

1. National Institute of Clinical and Health Excellence. http://www.nice.org.uk/ aboutnice/whatwedo/abouttechnologyappraisals/about_technology_appraisals.jsp (accessed Oct 2007).
2. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the economic evaluation of health care programmes. Second edition. Oxford: Oxford University Press, 1997.
3. Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford: Oxford University Press, 2006.
4. Shiell A, Donaldson C, Mitton C, et al. Health economic evaluation. J Epidemiol Community Health 2002;56:85-8.
5. National Institute of Clinical and Health Excellence. Guide to the methods of technology appraisal. May 2004. http://www.nice.org.uk/niceMedia/pdf/ TAP_Methods.pdf. (accessed Oct 2007).
6. Netten A, Dennett J, Knight J. Unit costs of health and social care. http://www. pssru.ac.uk/uc/uc2005contents.htm (accessed Oct 2007).
7. The Chartered Institute of Public Finance and Accountancy (CIPFA). The Health Service Database 2002-03. Croydon: CIFPA, 2003.
8. British National Formulary. http://www.bnf.org/bnf/
9. Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Second edition. Philadelphia: Lippincott-Raven, 1996.
10. Neumann PJ, Goldie SJ, Weinstein MC. Preference-based measures in economic evaluation in health care. Annu Rev Public Health 2000;21:587-611.
11. Dolan P, Gudex C, Kind P, et al. A social tariff for EuroQol: results from a UK general population survey. University of York Centre for Health Economics Discussion Paper Series (no. 138). York: Centre for Health Economics, 1995.
12. McCabe C, Stevens K, Roberts J, et al. Health state values for the HUI 2 descriptive system: results from a UK survey. Health Econ 2005;14:231-44.
13. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42:851-9.
14. Appleby J, Devlin N, Parkin D. NICE's cost effectiveness threshold. BMJ 2007;335:358-9.
15. Culyer A, McCabe C, Briggs A, et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy 2007;12:56-8.
16. Fenwick E, Byford S. A guide to cost-effectiveness acceptability curves. Br J Psychiatry 2005;187:106-8.
17. Iglesias C, Nixon J, Cranny G, et al; PRESSURE Trial Group. Pressure relieving support surfaces (PRESSURE) trial: cost effectiveness analysis. BMJ 2006;332:1416.
18. Manca A, Dumville JC, Torgerson DJ, et al. Randomized trial of two physiotherapy interventions for primary care back and neck pain patients: cost effectiveness analysis. Rheumatology (Oxford) 2007;46:1495-501.
19. Nixon J, Cranny G, Iglesias C, et al. Randomised, controlled trial of alternating pressure mattresses compared with alternating pressure overlays for the prevention of pressure ulcers: PRESSURE (pressure relieving support surfaces) trial. BMJ 2006;332:1413.
20. Moffett JK, Jackson DA, Gardiner ED, et al. Randomized trial of two physiotherapy interventions for primary care neck and back pain patients: 'McKenzie' vs brief physiotherapy pain management. Rheumatology 2006;45:1514-21.